10 employees
CartilaGen is a startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
2015
$25K
from 1 investors over 1 rounds
CartilaGen raised $25K on September 12, 2019
Investors: ISU Pappajohn Center for Entrepreneurship